| 2025 |
朱芳妮;劉祉岑;陳明吉, 2025.06, '房市恐慌購買與感知稀缺：新冠肺炎疫情期間之研究, ' 住宅學報, Vol.34, No.1, pp.21-55.(TSSCI), vol. 131642, Jun. 2025 |
| 2025 |
Lee, ShaoChen*;Robin K. Chou, 2025.06, 'Price Formation around Historical Highs in Retail-Dominated Stock Markets: Evidence from Taiwan, ' Pacific-Basin Finance Journal,.(SSCI)(*為通訊作者)(本論著未刊登但已被接受), vol. 135818, Jun. 2025 |
| 2025 |
Hsin-Yi Lin*;Yu-Hsiang Hsiao;Yu-Min Yen, 2025.06, 'State-Dependent Local Projections – the Dynamic Effects of Regime Transitions, ' Econometric Reviews, Vol.44, No.6, pp.745-769.(SSCI)(*為通訊作者), vol. 134535, Jun. 2025 |
| 2025 |
Konan Chan;Yanzhi Wang;Hsiao-Lin Yang, 2025.05, 'Organization Capital and Takeover Vulnerability, ' Review of Quantitative Finance and Accounting (國科會財務類A tier 2期刊), pp.forthcoming.(SSCI), vol. 135295, May. 2025 |
| 2025 |
Hsieh, Kai-Yu*, 2025.05, 'Direct investments in Japan and operational efficiency of semiconductor companies from Taiwan, ' AAOS Transactions, Vol.13, No.3, pp.1-12.(J-STAGE, 日本組織学会誌)(*為通訊作者), vol. 122343, May. 2025 |
| 2025 |
Shu-Ching Chou;Yu-Hsiu Cheng;Yenn-Ru Chen*, 2025.05, 'Grabbing or helping hand? The impact of government subsidies on innovation and performance for firms in cultural and creative industries, ' Review of Quantitative Finance and Accounting, Vol.64, No.4, pp.1719-1755.(SCOPUS, ESCI, 國科會財務領域A Tier 2期刊)(*為通訊作者), vol. 122299, May. 2025 |
| 2025 |
Ging‑Ginq Pan;許永明*;Tu‑Cheng Wu, 2025.04, 'Time-varying Predictability of TAIEX Volatility, ' Review of Derivatives Research, Vol.28, No.2, pp.NA.(SSCI)(*為通訊作者), vol. 136616, Apr. 2025 |
| 2025 |
Lo, S.M.*;Chang, Y.M., 2025.04, 'Utilizing business process management (BPM) for performance improvement: A case study of an express company in Taiwan, ' NTU Management Review, Vol.2025, No.2025, pp.1-18.(TSSCI, SCOPUS)(*為通訊作者)(本論著未刊登但已被接受), vol. 422920, Apr. 2025 |
| 2025 |
陳秉訓*, 2025.04, '以搭售產品之所失利益計算專利侵權之損害賠償─以美國CAFC判決為中心, ' 專利師季刊, No.61, pp.1-21.(月旦法學資料庫)(*為通訊作者), vol. 135126, Apr. 2025 |
| 2025 |
Ping-Hsun Chen*, 2025.04, 'Pleading Use of Trade Secrets Concerning a Biological Product by Showing Product-Related Similarities: Allergan, Inc. v. Revance Therapeutics, Inc., ' Biotechnology Law Report, Vol.44, No.2, pp.73-81.(SCIE)(*為通訊作者), vol. 135059, Apr. 2025 |
Powered by RulingDigital
